YUHSpace

BROWSE

YUHSpace1. College of Medicine (의과대학)Dept. of Obstetrics and Gynecology (산부인과학교실)

Dept. of Obstetrics and Gynecology (산부인과학교실)

Researcher List

Keyword Cloud

Journal Categories

Highly Cited Articles

MicroRNA expression profiles in serous ovarian carcinoma

Eun Ji Nam ; Heejei Yoon ; Sang Wun Kim ; Hoguen Kim ; Young Tae Kim ; Jae Ho... CLINICAL CANCER RESEARCH, Vol.14(9) : 2690-2695, 2008
PDF

Pre-treatment neutrophil to lymphocyte ratio is elevated in epithelial o...

HanByoul Cho ; Hye Won Hur ; Sang Wun Kim ; Sung Hoon Kim ; Jae Hoon Kim ; Yo... CANCER IMMUNOLOGY IMMUNOTHERAPY, Vol.58(1) : 15-23, 2009

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expr...

Funda Meric-Bernstam ; Vicky Makker ; Ana Oaknin ; Do-Youn Oh ; Susana Banerj... JOURNAL OF CLINICAL ONCOLOGY, Vol.42(1) : 47-58, 2024-01
PDF
This table browses all dspace content
Issue DateTitleJournal Title
2024Prognostic impact of intraoperative rupture in early-stage epithelial ovarian cancer: an ancillary study of GORILLA-3002EJSO
2024Prenatal Diagnosis and Clinical Outcomes of Isolated Mega Cisterna MagnaJOURNAL OF CHILD NEUROLOGY
2024Investigation of cell-to-cell transfer of polystyrene microplastics through extracellular vesicle-mediated communicationBIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
2024Changes in the tumor immune microenvironment during disease progression in clear cell ovarian cancerINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2024A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
2024Efficacy of Trastuzumab Deruxtecan in HER2-Expressing Solid Tumors by Enrollment HER2 IHC Status: Post Hoc Analysis of DESTINY-PanTumor02 ADVANCES IN THERAPY
2024Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): overall survival results from a randomised, double-blind, placebo-controlled, phase 3 trialLANCET
2024Recent Advances in Genomic Approaches for the Detection of Homologous Recombination Deficiency CANCER RESEARCH AND TREATMENT
2024From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps CANCERS
2024Therapeutic effects of surgical debulking of metastatic lymph nodes in cervical cancer IIICr: a trial protocol for a phase III, multicenter, randomized controlled study (KGOG1047/DEBULK trial) JOURNAL OF GYNECOLOGIC ONCOLOGY
2024Anti-4-1BB×PDL1 Bispecific Antibody Reinvigorates Tumor-Specific Exhausted CD8+ T Cells and Enhances the Efficacy of Anti-PD1 BlockadeCLINICAL CANCER RESEARCH
2024Pembrolizumab or Placebo With Chemoradiotherapy Followed by Pembrolizumab or Placebo for Newly Diagnosed, High-Risk, Locally Advanced Cervical Cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): A Randomized, Double-Blind, Phase 3 Clinical TrialOBSTETRICAL & GYNECOLOGICAL SURVEY
2024Impacts of Tocolytics on Maternal and Neonatal Glucose Levels in Women With Gestational Diabetes Mellitus JOURNAL OF KOREAN MEDICAL SCIENCE
2024Commentary: Thoracic Endometriosis: The Necessity of a Multidisciplinary Approach for Optimal TreatmentJournal of Chest Surgery
2024Bintrafusp Alfa for Recurrent or Metastatic Cervical Cancer After Platinum Failure: A Nonrandomized Controlled TrialJAMA ONCOLOGY
2024Effects of subcutaneous drain on wound dehiscence and infection in gynecological midline laparotomy: Secondary analysis of a Korean Gynecologic Oncology Group study (KGOG 4001)EJSO
2024GX-188E DNA vaccine plus pembrolizumab in HPV 16- and/or 18-positive recurrent or advance cervical cancer: a phase 2 trialECLINICALMEDICINE
2024Hormone replacement therapy and myocardial infarction and stroke in postmenopausal Korean womenCLIMACTERIC
2024A Comparative Study of Performance Between Federated Learning and Centralized Learning Using Pathological Image of Endometrial CancerJOURNAL OF IMAGING INFORMATICS IN MEDICINE
2024Efficacy of immune-checkpoint inhibitors combined with cytotoxic chemotherapy in advanced or recurrent endometrial cancer: A systematic review and meta-analysisGYNECOLOGIC ONCOLOGY
1234567891011 87
  • License
    sherpa_romeo
    sherpa_juliet

OAK

DSpace Software Copyright © 2002-2017 Duraspace Yonsei University Medical Library All right Reserves. / TEL:02-2228-2915 /
YUHSpace는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.

Browse

Links